GAMIDA CELL LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.017 USD | +2.41% |
|
+2.41% | -95.88% |
| May. 23 | Gamida Cell Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 10 | Gamida Cell Ltd.(NasdaqGM:GMDA) dropped from S&P Global BMI Index | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 144.8 | 484.7 | 150.6 | 95.95 | 54.74 | 2.619 |
| Enterprise Value (EV) 1 | 144.8 | 484.7 | 134.4 | 135.3 | 54.74 | 2.619 |
| P/E ratio | -3.68 x | -5.05 x | -1.67 x | -1.04 x | -0.72 x | -0.03 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | - | - | - | - | 30.7 x | 0.16 x |
| EV / Revenue | - | - | - | - | 30.7 x | 0.16 x |
| EV / EBITDA | - | - | - | - | - | - |
| EV / FCF | - | -8,021,047 x | -1,555,757 x | - | - | - |
| FCF Yield | - | -0% | -0% | - | - | - |
| Price to Book | - | - | 3.47 x | - | - | - |
| Nbr of stocks (in thousands) | 33,667 | 57,774 | 59,299 | 74,381 | 132,639 | 154,051 |
| Reference price 2 | 4.300 | 8.390 | 2.540 | 1.290 | 0.4127 | 0.0170 |
| Announcement Date | 2/25/20 | 3/9/21 | 3/15/22 | 3/27/23 | 3/27/24 | - |
1USD in Million2
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net sales 1 | - | - | - | - | 1.784 | 16.79 |
| EBITDA | - | - | - | - | - | - |
| EBIT 1 | -48.24 | -62.3 | -87.17 | -74.99 | -73.04 | -66.08 |
| Operating Margin | - | - | - | - | -4,094.06% | -393.53% |
| Earnings before Tax (EBT) 1 | -34.42 | -72.7 | -89.79 | -79.38 | -63 | -70.08 |
| Net income 1 | -34.35 | -72.7 | -89.79 | -79.38 | -63 | -71.64 |
| Net margin | - | - | - | - | -3,531.17% | -426.65% |
| EPS 2 | -1.170 | -1.660 | -1.520 | -1.240 | -0.5700 | -0.5700 |
| Free Cash Flow | - | -60.43 | -96.81 | - | - | - |
| FCF margin | - | - | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 2/25/20 | 3/9/21 | 3/15/22 | 3/27/23 | 3/27/24 | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Net Debt | - | - | - | 39.3 | - | - |
| Net Cash position | - | - | 16.2 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow | - | -60.4 | -96.8 | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | 0.7300 | - | - | - |
| Cash Flow per Share | - | - | - | - | - | - |
| Capex | - | - | 15.1 | - | - | - |
| Capex / Sales | - | - | - | - | - | - |
| Announcement Date | 2/25/20 | 3/9/21 | 3/15/22 | 3/27/23 | 3/27/24 | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -95.88% | 2.62M | |
| +8.92% | 114B | |
| +10.48% | 104B | |
| -1.83% | 22.57B | |
| -6.45% | 22.5B | |
| -10.39% | 17.95B | |
| -42.36% | 16.48B | |
| -14.45% | 15.82B | |
| +3.76% | 13.55B | |
| +28.94% | 10.99B |
- Stock Market
- Equities
- GMDA Stock
- Financials Gamida Cell Ltd.
